[Amynoglycoside-induced hearing loss].
Yamasoba
Tatsuya
T
Department of Otolaryngology, Tokyo University Graduate School of Medicine.
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D004272:DNA, Mitochondrial / Q000235:genetics; D003638:Deafness / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology; D003937:Diagnosis, Differential; D006801:Humans; D017354:Point Mutation; D011379:Prognosis; D012313:RNA; D000077278:RNA, Mitochondrial; D012335:RNA, Ribosomal; D013307:Streptomycin / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D004272:DNA, Mitochondrial; D000077278:RNA, Mitochondrial; D012335:RNA, Ribosomal; C075526:RNA, ribosomal, 12S; D012313:RNA; D013307:Streptomycin